Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127263) titled 'Effects of KRAS/NRAS/BRAF Mutations on the Clinicopathological Features of TP53-Mutant Colorectal Cancer' on June 28.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
Condition:
Colorectal cancer
Intervention:
Observation Group (TP53-mutated Colorectal cancer):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-28
Target Sample Size: Observation Group (TP53-mutated Colorectal cancer):75;Control group (non-TP53 mutant colorectal cancer):75;
Countries of Recruitment:
China
To ...